HUATAI SECURITIES Aktie

 

[The content of this article has been produced by our advertising partner.] Hong Kong, Mar 30, 2026 - Huatai Securities Co., Ltd. (the “Company”; stock codes: 601688.SH, 6886.HK, HTSC.L), a leading technology‑driven and fully integrated securities firm in China, announced its consolidated financial results for the year ended December 31, 2025. Annual Highlights: In 2025, the Company recorded total revenue of RMB 47.22 billion and net profit attributable to shareholders of RMB 16.38......

HTSC (06886.HK) announced its full-year results for the period ending last December. The revenue was RMB47.22 billion, representing a year-on-year increase of 1.9%. The net profit was RMB16.383 billion, up 6.7% year-on-year; the earnings per share were RMB1.73. A final dividend of RMB0.4 was declared, bringing the total dividend......

Huatai Securities published a report stating that Kangnuoai-B (02162.HK) announced Gilead will acquire Ouro, which holds the overseas rights to CM336, with an initial payment of USD1.675 billion and a USD500 million milestone payment. Following the transaction, Kangnuoai will receive an initial payment of RMB250 million and a US......

HTSC (06886.HK) opened 3.9% lower this morning (3rd) before its decline widened during the morning session. It once slipped to $16.66 during the intraday trading session, and last sank 9.16% to $16.76 after midday, with a trading volume of 64.9 million shares, involving $1.108 billion.HTSC earlier announced that it had entered i......

Leading Chinese broker Huatai Securities plans to raise up to HK$10 billion (US$1.3 billion) through the issuance of zero-coupon convertible bonds to support its international expansion, according to a Hong Kong stock exchange filing on Tuesday. The company expects net proceeds of about HK$9.9 billion after commissions and expenses, with the funds earmarked for overseas business development and to bolster working capital. The bonds will carry no interest and mature in February 2027. Investors......

HTSC (06886.HK) announced that it had entered into a subscription agreement with Huatai Financial Holdings (Hong Kong), UBS Group, and Goldman Sachs (Asia) as managers to issue zero-coupon convertible bonds due in 2027.The total principal amount of this proposed issuance is HKD10 billion. The bonds will be zero-coupon, and they ......

Huatai Securities kept rating at Buy for YADEA (01585.HK), with a target price of $18.63. The Company expected its 2025 net profit to be no less than RMB2.9 billion, representing a YoY growth of over 128%, primarily driven by the increase in electric two-wheeler sales and product structure optimization.The broker was optimistic ......

A leadership transition is underway at Huatai Securities Co. Ltd. (601688.SH), one of China's largest brokerages, as the firm navigates intensifying competition in China's consolidating securities industry. ... Read more...

Chinese brokers ascended, with HTSC (06886.HK) up 5.9%; GTHT (02611.HK) up 5.78%; CITIC SEC (06030.HK) up 3.69%; CMSC (06099.HK) up 3.36%; and CGS (06881.HK) up over 4%.Wu Qing, Chairman of the China Securities Regulatory Commission (CSRC), said that regulatory policies will focus on strengthening classified supervision, "s......

CHINA COMM CONS (01800.HK)(601800.SH)'s 1-3Q25 revenue was RMB513.915 billion, down 4.23% YoY, Huatai Securities issued a research report saying. Net profit attributable to the parent company amounted to RMB13.647 billion, down 16.14% YoY, while net profit excluding non-recurring items was RMB11.701 billion, down 13.45% YoY.......

SD GOLD (01787.HK)'s 3Q25 revenue was RMB27.017 billion, up 27.25% YoY and down 12.37% QoQ, with a net profit attributable to the parent company of RMB1.148 billion, Huatai Securities issued a research report saying. For 1-3Q25, the Company recorded a revenue of RMB83.783 billion, with a net profit attributable to the parent......

Das Instrument 206H CNE100001YQ9 HUATAI SECURIT.CO.H YC 1 EQUITY wird ex Dividende/Zinsen gehandelt am 31.10.2025 The instrument 206H CNE100001YQ9 HUATAI SECURIT.CO.H YC 1 EQUITY has its ex-dividend/interest day on 31.10.2025...

BEIJING, China (IT-Times) - Ein Analyst hat ein Research-Update zum Smartphone- und Automobilhersteller Xiaomi veröffentlicht und erwartet bald ein profitables Geschäft mit Elektroautos. Huatai Sec......

Huatai Securities has released a research report estimating XIAOMI-W (01810.HK)'s 3Q25 revenue to grow by 23% YoY to RMB113.4 billion on the back of its automotive business, while its non-GAAP net profit attributable to shareholders will increase by 63% YoY to RMB10.17 billion. Its automotive business is also predicted to tu......

CHINA UNICOM (00762.HK) recorded an operating revenue of RMB292.99 billion for 1-3Q25, up 0.99% YoY, Huatai Securities released a research report saying. Net profit attributable to the parent company (A-share caliber) was RMB8.772 billion, up 5.2% YoY, in line with the broker's previous earnings forecast of RMB8.786 billion.......

Huatai Securities has released a research report raising its target prices for SMIC's (00981.HK) (688981.SH) H-shares from HKD63 to HKD119 and for its A-shares from RMB118.3 to RMB238, with a Buy rating remaining in place.The broker also maintained its 2025-27 net profit forecasts for SMIC, predicting YoY increases of 26%/ 2......

Huatai Securities issued a research report elevating its target price for HUA HONG SEMI (01347.HK) from $53 to $119, with rating kept at Buy. The broker also maintained its YoY growth forecasts for the Company's net profit attributable to parent company at 3%/ 48%/ 16% for 2025-2027, reaching US$60 million/ 89 million/ 103 m......

Huatai Securities issued a research report being optimistic about the investment value of HSBC HOLDINGS (00005.HK). The core logic lies in its strategic positioning and structural adjustments, resonating with the recovery of the Hong Kong capital market. The Fed's resumption of interest rate cuts and the RMB appreciation exp......

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

A-share listed mainland medical equipment manufacturer MINDRAY BIO-MEDICAL (300760.SZ) has selected Huatai Securities and JPMorgan to handle the preparation work for its IPO in Hong Kong, Bloomberg reported, quoting people with the knowledge of the matter.More investment banks may be brought in later for this listing. Earlier ma......